Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Schering-Plough will not enter new exclusivity period to negotiate celgosivir license

July 2, 2007

Amendment to Lialda agreement

July 2, 2007

FDA grants fast track designation for HCV-796

July 2, 2007

New phase II trial evaluates SCV-07 for HCV

June 29, 2007

Positive results for Theravance's phase II study of TD-5108

June 29, 2007

New trials commence for Heplisav

June 28, 2007

Gilead reports promising phase III results for chronic hepatitis B

June 28, 2007

Recent GSK patent discloses novel therapeutic agents for gastrointestinal disorders

June 27, 2007

PegIntron and Rebetol approved in E.U. for HCV patients coinfected with HIV

June 26, 2007

Oncolys and Tacere to jointly develop TT-033 for hepatitis C

June 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...